相关实验视频
Updated: Jun 5, 2025

07:54
Cholesterol Efflux Assay
Published on: March 6, 2012
29.8K
GOLM1通过ABCG5介导的胆固醇排放促进胆固醇胆结石的形成,在与代谢功能障碍相关的脂肪肝肝炎肝脏中
Yi-Tong Li1, Wei-Qing Shao1, Zhen-Mei Chen1
1Hepatobiliary Surgery, Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, China.
Clinical and molecular hepatology
|December 10, 2024
概括
与代谢功能障碍相关的脂肪肝炎 (MASH) 增加了胆结石风险. 戈尔吉膜蛋白1 (GOLM1) 通过通过骨质疏通调节ABCG5介导的胆固醇外流,促进MASH中的胆固醇结石形成.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 分子生物学分子生物学
- 胃肠病学 胃肠病学
背景情况:
- 代谢功能障碍相关的脂肪肝炎 (MASH) 是胆结石形成的已知危险因素.
- 连接MASH与胆结石发展的确切机制尚未完全理解.
- 戈尔吉膜蛋白1 (GOLM1) 参与肝脏胆固醇代谢,在MASH中升高.
研究的目的:
- 调查GOLM1在与MASH相关的胆固醇胆结石 (CGS) 的形成中的作用.
- 阐明GOLM1影响MASH中的胆固醇代谢和胆结石发育的分子机制.
主要方法:
- 用英国生物银行队列进行病因分析.
- 使用GOLM1淘汰和野生型小鼠食高脂肪饮食 (HFD) 来诱导MASH并评估胆结石形成.
- 进行了组织学,免疫组织化学和胆汁脂质分析;利用HepG2细胞进行机械学研究和人类肝脏样本进行临床验证.
主要成果:
- 患有MASH的患者表现出 cholelithiasis 的风险增加.
- 在小鼠中,HFD诱导的MASH在野生型 (75.0%) 与GOLM1淘汰 (16.7%) 的小鼠相比显示出明显更高的胆结石发病率.
- 发现GOLM1通过骨质素 (OPN) 调节ATP结合磁带载体子家族G成员5 (ABCG5) 介导的胆固醇流量,通过因特鲁金-1β (IL-1β) 刺激的过程.
结论:
- 在MASH肝脏中,IL-1β对GOLM1的升级促进了通过增强的ABCG5介导胆固醇外流以OPN依赖的方式促进CGS的形成.
- GOLM1是MASH和胆固醇胆结石形成之间的关键分子环节.
- 在MASH患者中,GOLM1代表了管理胆结石的潜在治疗标.
相关概念视频
Cholesterol: Significance and Regulation
504
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
504
Lipid Absorption
374
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
374
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
532
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
532
Overview of Fatty Acid Metabolism
30.2K
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
30.2K
Diseases of the Liver and Gallbladder
467
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
467
Hepatic Drug Clearance: Role of Transporters
35
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
35

